Track the 테라젠이텍스 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 테라젠이텍스 has recorded 2 reports. Market capitalisation: €73.7bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 테라젠이텍스. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Teragen Etex is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions in the biotechnology field.